A

Annovis Bio

D
ANVS
USD
0.12
(1.4068%)
Market Closed
2,191.00
Volume
-1.7
EPS
-
Div Yield
-1.905286
P/E
112,917,255.70
Market Cap
Today
1.4068%
1 Week
-6.486%
1 Month
5.875%
6 Months
62.594%
12 Months
48.881%
Year To Date
-53.867%
All Time
0%
News

Treasury Yields Decline as Market Anticipates Fed Rate Cuts

26.08.2024
Economy news

Novo Nordisk Surges in Profit and Sales

02.05.2024
Stocks news
More
Related Instruments
A
APLS
-0.11
(-0.3809%)
USD
C
CRBP
-0.36
(-1.9027%)
USD
M
MEIP
0.02
(0.6472%)
USD
B
BLPH
(%)
USD
B
BGNE
4.44
(2.1924%)
USD
C
CTMX
-0.0026
(-0.2594%)
USD
D
DARE
0.14
(3.5714%)
USD
F
FATE
-0.24
(-8.6022%)
USD

Title:
Annovis Bio

Sector:
Healthcare
Industry:
Biotechnology
Annovis Bio Inc is a clinical-stage pharmaceutical company focused on developing and commercializing drugs for the treatment of Parkinson's and Alzheimer's diseases and other neurodegenerative diseases. The pipeline products of the companyconsists of: Buntanetap for chronic neurodegeneration - including AD and PD; ANVS405 for acute neurodegeneration; and ANVS301 for advanced AD.
Do you need help or have a question?
Contact Us